Novo Nordisk is trading 5.76% down now at $40.61 as its September 21, 2026 Capital Markets Day raises investor concerns about the company’s growth outlook. - M

Novo Nordisk is trading 5.76% down now at $40.61 as its September 21, 2026 Capital Markets Day raises investor concerns about the company’s growth outlook. - Management plans to launch more than five blockbuster drugs by 2030 and generate over 150 billion Danish kroner in pipeline sales by 2035. - …